Barts Experimental Cancer Medicine Centre
@BartsECMC
Leading cancer centre committed to outstanding patient care and innovative research. Follow for first look of our work!
07-10-2021 09:42:23
250 Tweets
407 Followers
200 Following
Dr Matthew Young from Barts Experimental Cancer Medicine Centre presenting data on the predictive value of dynamic changes in ctDNA and baseline biomarkers with neoadjuvant atezolizumab in operable urothelial carcinoma. Data from the ABACUS trial. abstract 543. Tom Powles
